Giovanni V. Gaudio

Varese, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Inclisiran for fast-track lipid-lowering treatment early after an acute coronary syndrome: a pilot study.

Inclisiran for fast-track lipid-lowering treatment early after an acute coronary syndrome: a pilot study.

Journal: Atherosclerosis plus
Published: May 27, 2025

Nutraceuticals and Supplements in Management of Prediabetes and Diabetes.

Nutraceuticals and Supplements in Management of Prediabetes and Diabetes.

Journal: Nutrients
Published: May 12, 2024

ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON).

ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON).

Journal: Journal of diabetes and its complications
Published: December 20, 2022

Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial.

Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial.

Journal: Frontiers in nutrition
Published: December 31, 2021

Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.

Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.

Journal: ESC heart failure
Published: March 17, 2021

Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report.

Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report.

Journal: Clinical Medicine Insights. Cardiology
Published: August 17, 2020

TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis.

TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis.

Journal: Internal and emergency medicine
Published: April 03, 2020

Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markErs in the progreSsion of dIabeteS in obese paTIeNts (The RESISTIN trial).

Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markErs in the progreSsion of dIabeteS in obese paTIeNts (The RESISTIN trial).

Journal: Cytokine
Published: August 11, 2019

A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients.

A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients.

Journal: Drug design, development and therapy
Published: September 11, 2018

Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry.

Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry.

Journal: Thrombosis and haemostasis
Published: April 05, 2018

Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial.

Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 30, 2017

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: September 11, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026